Lineage Cell Therapeutics, Inc.

LCTX·NYSE American
Compare
0.9541−0.0399 (−4.01%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.9940
Open0.9979
Day range0.93860.9823
52-week range0.88002.0900
Off day high−2.87%
Off 52-week high−54.35%
Volume1.69M
Avg. volume (3M)1.18M
Market cap241.30M
EPS (TTM)-0.2000
Forward P/E-6.94
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding252.91M
Short interest—
Earnings dateAug 6, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
LCTX OCGN IRD IPSC RGNX CELU
Market cap 241.30M 321.21M 386.03M 260.75M 512.92M 47.70M
P/E (TTM) — — — — — —
Forward P/E -6.9 -3.7 -6.5 -3.2 -2.6 -2.6
Price/book 4.0 -19.3 -29.6 1.1 5.9 -1.2
Dividend yield — — — — — —
1-year change −46.93% −41.90% +132.00% +157.14% −30.93% −35.24%
Today −4.01% −0.87% −0.22% −2.04% −3.72% −5.77%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All LCTX news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.